Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical study
<p>Abstract</p> <p>Background</p> <p>Histological malignancy grading of astrocytomas can be challenging despite criteria given by the World Health Organisation (WHO). Grading is fundamental for optimal prognostication and treatment, and additional biomarkers are needed...
Saved in:
Main Authors: | Gulati Sasha (Author), Habberstad Andreas H (Author), Torp Sverre H (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overexpression of c-<it>erb</it>B2 is a negative prognostic factor in anaplastic astrocytomas
by: Gulati Michel, et al.
Published: (2010) -
Practical value of MIB-1 index in predicting behavior of astrocytomas
by: M Moses Ambroise, et al.
Published: (2011) -
Predictive value of morphological features and proliferative markers (mitotic index, Ki-67, PHH3) in bronchopulmonary neuroendocrine tumors
by: L. M. Zakhartseva, et al.
Published: (2021) -
Frequency of Ki-67 (MIB-1) and P53 expressions among patients with prostate cancer
by: Seyed Hamid Madani, et al.
Published: (2011) -
Role of topoisomerase II α and Ki -67 biomarkers in pituitary tumors
by: Chhanda Das, et al.
Published: (2023)